24 results
Thumbnail

D1.39 - Differential Diagnosis of Perioperative Anaphylaxis: The Hidden Role of Chlorhexidine

Thumbnail

D1.28 - Anaphylaxis after appendectomy: A case of allergy to sugammadex

Thumbnail

D1.29 - Class III Chitinases as Potential Allergens in Raspberry-Induced Anaphylaxis

Thumbnail

D1.30 - An exotic anaphylaxis in the mediterranean: due to a clinical case

Thumbnail

D1.31 - Quality Of Life In Alexithymic Patients With Anaphylaxis

Thumbnail

D1.32 - The effect of chelation on carmine allergy induced by epicutaneous sensitization to carmine in cosmetics

Thumbnail

D1.33 - Oat Allergy in a Young Adult: Allergenic Protein Profiling and Clinical Implications

Thumbnail

D1.34 - Hypersensitivity Reactions to Iodinated and Gadolinium-Based Contrast Media: Clinical and Epidemiological Insights

Thumbnail

D1.35 - Lipid transfer protein and Profilin-associated food-dependent exercise-induced anaphylaxis: A case series

Thumbnail

D1.36 - Prevalence of thaumatin and Alternaria co-sensitization

Thumbnail

D1.42 - Case Report of Allergy to Mint and Basil

Thumbnail

D1.43 - Performance Evaluation of a Semi-Quantitative Rapid Test Kit for Dust Mites: For Home Self-Monitoring and Control Effectiveness Assessment

Thumbnail

D1.37 - Sometimes it is not what it seems

Thumbnail

D1.38 - Anaphylactic reaction to chia seeds: A case report

Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab